2,449
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report

ORCID Icon, &
Article: 2208010 | Received 22 Feb 2023, Accepted 24 Apr 2023, Published online: 03 May 2023

Figures & data

Figure 1. The treatment components of AIHA during the first hospital stay (days 0–71) (A) of the patient are listed in the bottom table and the corresponding effects on the hemoglobin (Hb) values (red line) and hemolysis activity (i.e. LDH (black) and total bilirubin (blue)) are depicted above. In (B) the course of AIHA is demonstrated after the first hospital release of the patient until day 148. The last RBC transfusion was on day 108. Abbreviations: RBC-Red blood cells; IVIG-Intravenous immunoglobulin; LDH-Lactate dehydrogenase.

Figure 1. The treatment components of AIHA during the first hospital stay (days 0–71) (A) of the patient are listed in the bottom table and the corresponding effects on the hemoglobin (Hb) values (red line) and hemolysis activity (i.e. LDH (black) and total bilirubin (blue)) are depicted above. In (B) the course of AIHA is demonstrated after the first hospital release of the patient until day 148. The last RBC transfusion was on day 108. Abbreviations: RBC-Red blood cells; IVIG-Intravenous immunoglobulin; LDH-Lactate dehydrogenase.